MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-16-2026
NeuroMetrix Operating Cash Flow 2011-2026 | NURO
Annual Operating Cash Flow NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.13 M | -6.08 M | -5.29 M | -2.07 M | -2.07 M | -3.62 M | 2.86 M | -12.7 M | - | - | - | -6.55 M | -9.18 M | -6.78 M | -13.3 M | -6.14 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.86 M | -13.3 M | -6 M |
Quarterly Operating Cash Flow NeuroMetrix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.24 M | -3.45 M | -2.08 M | - | -4.63 M | -2.57 M | -1.12 M | - | -3.81 M | -1.58 M | -740 K | - | -1.56 M | -569 K | -33.8 K | - | -2.35 M | -1.83 M | -763 K | - | -3.56 M | -1.82 M | 420 K | - | 3.58 M | 3.2 M | 2.08 M | - | -9.48 M | - | - | - | - | - | - | - | - | - | - | - | - | -3.44 M | -1.61 M | - | -5.33 M | -3.66 M | -1.8 M | - | -6.97 M | -4.63 M | -2.59 M | - | -5.34 M | -3.46 M | -1.85 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.58 M | -9.48 M | -2.38 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
796 M | $ 68.26 | -0.53 % | $ 13.6 B | USA |
 |
Glaukos Corporation
GKOS
|
-14.8 M | $ 122.04 | -3.48 % | $ 6.98 B | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 417.73 | -2.08 % | $ 149 B | USA |
 |
Alcon
ALC
|
1.34 B | $ 66.83 | -1.58 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
180 M | $ 142.92 | 0.64 % | $ 3.52 B | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 115.08 | 1.1 % | $ 3.68 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 3.99 | -0.25 % | $ 184 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 94.74 | -1.92 % | $ 2.14 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 179.95 | - | $ 9.59 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 1.81 | -0.82 % | $ 82.9 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.4 | 2.35 % | $ 32.8 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 67.71 | 0.3 % | $ 4.01 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 9.74 | 2.31 % | $ 82.6 K | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 24.56 | -0.12 % | $ 4.13 B | USA |
 |
Haemonetics Corporation
HAE
|
293 M | $ 79.71 | 1.23 % | $ 3.76 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
1.34 B | $ 210.08 | -1.32 % | $ 20.6 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 29.89 | 0.07 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
24.4 M | $ 8.9 | -1.5 % | $ 184 M | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 68.56 | 0.72 % | $ 222 M | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 331.36 | -1.06 % | $ 24 B | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 24.86 | -3.53 % | $ 1.68 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 10.41 | -0.62 % | $ 2.08 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.69 | -0.13 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 63.0 | -3.08 % | $ 207 M | USA |
 |
Predictive Oncology
POAI
|
-13.2 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
20.1 M | $ 27.35 | -0.73 % | $ 1.31 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.85 | - | $ 168 M | USA |
 |
Baxter International
BAX
|
845 M | $ 20.61 | 2.87 % | $ 10.6 B | USA |
 |
ResMed
RMD
|
351 M | $ 195.84 | -0.56 % | $ 28.6 B | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 27.3 | - | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 6.18 | 2.32 % | $ 274 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 12.4 | 0.49 % | $ 507 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 150.41 | -1.08 % | $ 43.3 B | USA |
 |
Nephros
NEPH
|
1.64 M | $ 3.24 | -0.46 % | $ 34.4 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 4.17 | -1.65 % | $ 306 M | USA |
 |
Repligen Corporation
RGEN
|
117 M | $ 133.01 | 2.21 % | $ 7.48 M | USA |